INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY, UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC FILES APPLICATION FOR "MIR-211 AND ACSL4 AS THERAPEUTIC AGENTS FOR CHILDHOOD CANCER MEDULLOBLASTOMAS"

GENEVA, June 12 -- THE JOHNS HOPKINS UNIVERSITY (3400 North Charles St.Baltimore, Maryland 21218), UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC (12201 Research Parkway, Ste. 501Orlando, Florida 32816) filed a patent application (PCT/US2024/057873) for "MIR-211 AND ACSL4 AS THERAPEUTIC AGENTS FOR CHILDHOOD CANCER MEDULLOBLASTOMAS" on Nov 27, 2024. With publication no. WO/2025/117832, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PERERA, Ranjan J. (c/o The Johns Hopkins University3400 North Charles St.Baltimore,...